Methyl 8- and 5-Nitro-1,4-Benzodioxane-2-Carboxylate
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
Methyl 8-Nitro-1,4-benzodioxane-2-carboxylate (3) and Methyl-5-nitro-1,4-benzodioxane-2-carboxylate (4)
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bolchi, C.; Bavo, F.; Appiani, R.; Roda, G.; Pallavicini, M. 1,4-Benzodioxane, an evergreen, versatile scaffold in medicinal chemistry: A review of its recent applications in drug design. Eur. J. Med. Chem. 2020, 200, 112419. [Google Scholar] [CrossRef] [PubMed]
- Muszak, D.; Surmiak, E.; Plewka, J.; Magiera-Mularz, K.; Kocik-Krol, J.; Musielak, B.; Sala, D.; Kitel, R.; Stec, M.; Weglarczyk, K.; et al. Terphenyl-based small-molecule inhibitors of programmed cell death-1/programmed death-ligand 1 protein-protein interaction. J. Med. Chem. 2021, 64, 11614–11636. [Google Scholar] [CrossRef] [PubMed]
- Lu, Y.; Vibhute, S.; Li, L.; Okumu, A.; Ratigan, S.C.; Nolan, S.; Papa, J.L.; Mann, C.A.; English, A.; Chen, A.; et al. Optimization of TopoIV potency, ADMET properties, and hERG inhibition of 5-amino-1,3-dioxane-linked novel bacterial topoisomerase inhibitors: Identification of a lead with in vivo efficacy against MRSA. J. Med. Chem. 2021, 64, 15214–15249. [Google Scholar] [CrossRef] [PubMed]
- Pasqua, A.E.; Sharp, S.Y.; Chessum, N.E.A.; Hayes, A.; Pellegrino, L.; Tucker, M.J.; Miah, A.; Wilding, B.; Evans, L.E.; Rye, C.S.; et al. HSF1pahway inhibitor clinical candidate (CCT361814/NXP800) developed from a phenotypic screen as a potential treatment for refractory ovarian cancer and other malignancies. J. Med. Chem. 2023, 66, 5907–5936. [Google Scholar] [CrossRef] [PubMed]
- Bolchi, C.; Valoti, E.; Straniero, V.; Ruggeri, P.; Pallavicini, M. From 2-aminomethyl-1,4-benzodioxane enantiomers to unichiral 2-cyano- and 2-carbonyl-substituted benzodioxanes via dichloroamine. J. Org. Chem. 2014, 79, 6732–6737. [Google Scholar] [CrossRef] [PubMed]
- Bavo, F.; Pallavicini, M.; Gotti, C.; Appiani, R.; Moretti, M.; Colombo, S.F.; Pucci, S.; Viani, P.; Budriesi, R.; Renzi, M.; et al. Modifications at C(5) of 2-(2-pyrrolidinyl)-substituted 1,4-benzodioxane elicit potent α4β2 nicotinic acetylcholine receptor partial agonism with high selectivity over the α3β4 subtype. J. Med. Chem. 2020, 63, 15668–15692. [Google Scholar] [CrossRef] [PubMed]
- Bavo, F.; Pallavicini, M.; Appiani, R.; Bolchi, C. Determinants for α4β2 vs. α3β4 subtype selectivity of pyrrolidine-based nAChRs ligands: A computational perspective with focus on recent cryo-em receptor structures. Molecules 2021, 26, 3603. [Google Scholar] [CrossRef] [PubMed]
- Bouissane, L.; Khouili, M.; Coudert, G.; Pujol, M.D.; Guillaumet, G. New and promising type of leukotriene B4 (LTB4) antagonists based on the 1,4-benzodioxine structure. Eur. J. Med. Chem. 2023, 254, 115332. [Google Scholar] [CrossRef] [PubMed]
- Bolchi, C.; Bavo, F.; Pallavicini, M. Preparation and unequivocal identification of the regioisomers of nitrocatechol monobenzyl ether. Synth. Commun. 2017, 47, 1507–1513. [Google Scholar] [CrossRef]
- Armano, E.; Giraudo, A.; Pallavicini, M.; Bolchi, C. Methyl 8- and 5-bromo-1,4-benzodioxane-2-carboxylate: Unambiguous identification of the two regioisomers. Molbank 2023, 2023, M1623. [Google Scholar] [CrossRef]
- Elgaher, W.A.M.; Hamed, M.M.; Baumann, S.; Herrmann, J.; Siebenbürger, L.; Krull, J.; Cirnski, K.; Kirschning, A.; Brönstrup, M.; Müller, R.; et al. Cystobactamid 507: Concise synthesis, mode of action, and optimization toward more potent antibiotics. Chem. Eur. J. 2020, 26, 7219–7225. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Armano, E.; Giraudo, A.; Morano, C.; Pallavicini, M.; Bolchi, C. Methyl 8- and 5-Nitro-1,4-Benzodioxane-2-Carboxylate. Molbank 2023, 2023, M1661. https://doi.org/10.3390/M1661
Armano E, Giraudo A, Morano C, Pallavicini M, Bolchi C. Methyl 8- and 5-Nitro-1,4-Benzodioxane-2-Carboxylate. Molbank. 2023; 2023(2):M1661. https://doi.org/10.3390/M1661
Chicago/Turabian StyleArmano, Edoardo, Alessandro Giraudo, Camillo Morano, Marco Pallavicini, and Cristiano Bolchi. 2023. "Methyl 8- and 5-Nitro-1,4-Benzodioxane-2-Carboxylate" Molbank 2023, no. 2: M1661. https://doi.org/10.3390/M1661
APA StyleArmano, E., Giraudo, A., Morano, C., Pallavicini, M., & Bolchi, C. (2023). Methyl 8- and 5-Nitro-1,4-Benzodioxane-2-Carboxylate. Molbank, 2023(2), M1661. https://doi.org/10.3390/M1661